Cargando…

Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report

Detalles Bibliográficos
Autores principales:	Streicher, Caroline, Engalenc, Xavier, Gaudin, Marion, Vignaud, Guillaume, Daulange, Annick, Abraham, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502217/ https://www.ncbi.nlm.nih.gov/pubmed/32951190 http://dx.doi.org/10.1007/s40261-020-00969-5

Ejemplares similares

Why tocilizumab could be an effective treatment for severe COVID-19?
por: Fu, Binqing, et al.
Publicado: (2020)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Attraction to similar options: The Gestalt law of proximity is related to the attraction effect
por: Izakson, Liz, et al.
Publicado: (2020)

Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
por: Ortiz, Gustavo, et al.
Publicado: (2014)

Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
por: Youssief, Ayatallah A, et al.
Publicado: (2022)

Current Therapeutic Options for Heart Failure in Elderly Patients
por: Guerra, F., et al.
Publicado: (2017)

TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
por: Anwaar, Muhammad Faraz, et al.
Publicado: (2023)

MSC-Exosomes Carrying miRNA – Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19?
por: Schultz, Iago C., et al.
Publicado: (2022)

Cinacalcet: A Viable Therapeutic Option for Primary Hyperparathyroidism in the Elderly
por: Abusahmin, Hussam, et al.
Publicado: (2018)

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
por: Sisay, Mekonnen
Publicado: (2020)

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
por: Batoni, Giovanna, et al.
Publicado: (2022)

Multiple measures could alleviate long-branch attraction in phylogenomic reconstruction of Cupressoideae (Cupressaceae)
por: Qu, Xiao-Jian, et al.
Publicado: (2017)

Therapeutic options for severe asthma
por: Mathew, Jilcy, et al.
Publicado: (2012)

Integrins as attractive targets for cancer therapeutics
por: Li, Meng, et al.
Publicado: (2021)

Pancreatic cancer: Surgery is a feasible therapeutic option for elderly patients
por: Lahat, Guy, et al.
Publicado: (2011)

Radical pancreaticoduodenectomy in elderly patients: a feasible and adequate therapeutic option?
por: Garavoglia, Marcello, et al.
Publicado: (2013)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
por: Gardin, Chiara, et al.
Publicado: (2020)

How offshore wind could become economically attractive in low-resource regions like Indonesia
por: Langer, Jannis, et al.
Publicado: (2022)

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Minimally Invasive Transforaminal Lumbar Interbody Fusion: An Attractive Option for Select Failed Backs
por: Kulkarni, Arvind G., et al.
Publicado: (2018)

Spinal Cord Stimulation: Viable Therapeutic Option for Postlaminectomy Syndrome in Elderly Patients
por: Hallo, Alejandro, et al.
Publicado: (2021)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

BET Proteins as Attractive Targets for Cancer Therapeutics
por: Sarnik, Joanna, et al.
Publicado: (2021)

Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis – focus on subcutaneous tocilizumab
por: Nakashima, Yasuharu, et al.
Publicado: (2014)

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013)

Therapeutic Options of Chondrodermatitis Nodularis Helicis
por: Juul Nielsen, Lea, et al.
Publicado: (2016)

Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?
por: Saunier, Aurélie, et al.
Publicado: (2017)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis
por: Watanabe, Ryu, et al.
Publicado: (2014)

Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?
por: Koo, Chung Mo, et al.
Publicado: (2017)

When a repellent becomes an attractant: harmful saponins are kairomones attracting the symbiotic Harlequin crab
por: Caulier, Guillaume, et al.
Publicado: (2013)

Therapeutic Effect of Tocilizumab on Inhibiting Cytokine Release Syndrome in Severe Coronavirus Disease 2019 Patients
por: Xu, Lengnan, et al.
Publicado: (2022)

Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option
por: Argentiero, Antonella, et al.
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?
por: Takagi, Hisato
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lucgjg5j47n34pcghnfqb8poqo